Monitoring Protocol For patients taking both spironolactone (any indication) and rosuvastatin, the following monitoring protocol aligns with Endocrine Society and ACC/AHA lipid guidelines: Baseline (before co-initiation): Comprehensive metabolic panel including potassium, creatinine, eGFR Fasting lipid panel CK level (only if patient reports baseline myalgia) Hepatic transaminases (ALT) Week 1 after co-initiation: Repeat potassium
Research applications include investigations into NAD+ metabolism, mitochondrial function, and metabolic adaptation
Essentially the injection may be a temporary measure to fix levels
Colonic bacterial composition in Parkinson's disease
Gastroenterological endoscopy, 1981;23:2:241-247 Shatz BA, et al
Lucie, or utilized independently based on your clinical evaluation and personal weight loss goals